TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: fluctuation level of vitamin D
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of adrenal insufficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Functional outcome measured by mRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exercise Tolerance : 6 minute walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaccination coverage rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of nocturnal orthoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in lower limb protein balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disturbing Dreams and Nightmare Severity Index
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Incremental cost per quality-adjusted life-years (QALY) gained
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change from baseline upper extremity impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite score of events occurring within 30 days of transfusion
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of first unplanned hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: In-hospital cardiac arrest
Endpoint domain: Mortality/survival
Primary endpoint: Ratio of tumor necrosis factor-α to interleukin-10
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Splenic stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative serum prealbumin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Postoperative transferrin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Postoperative retinol-binding protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of anal HSIL and cancer
Endpoint domain: Mortality/survival
Primary endpoint: remission rate of aGVHD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proportion of patients achieving TMA Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KLH-induced immune reaction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: University of California at Los Angeles Activity Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in corneal high order aberrations (HOA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of rare bleeding disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Hemostasis of intraprocedural bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Concentration of Deoxycholic Acid (DCA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation between Enterobacteriaceae and NOTCH3 expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of weekly CSBMs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Enrolment of at least 50 participants across all sites within 9 months
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Trunk Position Sense measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: treatment-free remission
Endpoint domain: Mortality/survival
Primary endpoint: AUC0-28d
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC28-56d
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Midline discrepancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Individual crown width disproportions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distributed crown width disproportions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants with local injection site and systemic adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants with joint related symptoms, rash and unsolicited AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants with neurologic AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants with medically-attended AEs (MAAEs) and serious AEs (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of participants with recombinant vesicular stomatitis virus (rVSV) RNA in plasma, urine and saliva
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Size of bone particles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence or absence of collagen fibrils
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of calcium and phosphorus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Severity of MAFLD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Electrocardiogram (heart rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total oxidant/antioxidant load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Model performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Level of Fecal elastase-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of microorganisms resistant to the antimicrobial
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Cardiac volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cardiac strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Montgomery Åsberg Depression Rating Scale Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Knee Osteoarthritis Outcome Score Junior (KOOS JR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Forgotten Joint Score 12 (FJS-12 Knee)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Neurological survival after CA
Endpoint domain: Mortality/survival
Primary endpoint: Intent to Change Treatment Decisions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of High Risk Patients Who Develop Grade III or IV aGvHD
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patient's visits to doctors
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of exams performed
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of medical specialties consulted
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Changes in Quality of Life by EuroQoL-5D
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Participants Achieving at least a 75% Reduction in PASI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Instrument to measure Self-Management (IMSM)
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Relative dose intensity (RDI) of exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exercise sessions requiring dose modifications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective rating of the exercise session
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Exercise sessions attendance rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Median OS time
Endpoint domain: Mortality/survival
Primary endpoint: Scanning accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of desensitizing agent Propolis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurophysiology of Pain Questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Jebsen-Taylor Small Common Objects Functional Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Respiratory parameters (Inhalation and Exhalation time and ratio)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Frequency of local and systemic adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Anti-SARS-CoV-2 serum average life
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with change in COVID-19 disease progression profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of TFH cells and their activation markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in pre-existing immunity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: puncture site
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Hand-Foot Syndrome (HFS)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of subjects experiencing adverse events and serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in Human Leukocyte Antigen DR isotype (HLADRhi)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in children's physical literacy (fundamental movement skills)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in children's physical literacy (motivation and enjoyment; parental report)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in children's physical literacy (enjoyment; child report)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: One-year local control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of nail fold capillary changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 28 days in-hospital mortality
Endpoint domain: Mortality/survival
Primary endpoint: arterial stiffness change to exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: arterial viscosity change to exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: systolic and diastolic blood pressure change to exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cardiac sympathetic function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cardiac parasympathetic function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cerebral oxygenation level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Primary Symptom Improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hemoglobin oxygen saturation in a localized tissue (foot)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: duration
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Post-extubation distress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative expression of lncRNAs (NEAT1 and MALAT1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TIPS shunt dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PTX3 and HBP concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to wake-up after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive function using CANTAB-MCI
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Lipemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of adverse events defined as grade 3 or higher toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: patient pain
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Changes of carotid intima-media thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Z-score (BMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bioelectrical impedance analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Offensive Effectiveness Index (OEI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxious symptoms score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Depressive symptoms score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-reported partner notification
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Partner-confirmed notification
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Stability of crestal bone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes of stability of soft tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of position of implant using surgical guide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in functional connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in reaction time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction in QRS duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Whole exome sequencing of tumoral cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Averaged longitudinal strain of the left ventricle (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Occurrence of Adverse Events related to the study procedure
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in mean Montreal Cognition Assessment (MoCA) scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in mean CNS Vital Signs Neurocognitive Index Scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from Falls Efficacy Scale International (FES-I)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Functional Reach Test (FRT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes from Mini Balance Evaluation Systems Test (Mini-BESTest)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plaque fibrous cap thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Quality of Maternal and Newborn Care Index evaluated by women
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Quality of Maternal and Newborn Care Index evaluated by health professionals
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Total number of AEs/SAEs related and non-related to AdMSC infusion
Endpoint domain: Adverse events/effects
Primary endpoint: COVID-19 incidence rates
Endpoint domain: Mortality/survival
Primary endpoint: Questionnaire assessment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean change in intra-ocular pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective PTSD symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Site reproducibility of Knee MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dysfunctional breathing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Veterans specific activity questionnaire (VSAQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Amount of Wound Drainage (ml)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of early hepatobiliary malignancies detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Tissue of origin (TOO) accuracy of a cfDNA methylation-based model
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Proportion of subjects with GAIS equal to 'improved or much improved'
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of subjects with a ≥1-point change in the Marionette Line scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of gambling behaviors
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Core muscles strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glycosylated Hemoglobin (HbA1c) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Tear break-up time (TBUT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Change in maximal voluntary contraction force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in NMES-evoked force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in estimates of persistent inward current
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: early recurrence in hepatocellular cancer
Endpoint domain: Mortality/survival
Primary endpoint: Result of the SsIR/NIE ELISA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gingival Index (GI) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: Turesky modification of Quigley-Hein Plaque Index (TQHPI) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: Approximal Plaque Index (API) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oral health outcomes
Primary endpoint: anastomotic leak
Endpoint domain: Adverse events/effects
Primary endpoint: anastomotic stenosis
Endpoint domain: Adverse events/effects
Primary endpoint: laryngeal nerve injury
Endpoint domain: Adverse events/effects
Primary endpoint: Immune related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Bacterial vaginosis cure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Healthy Lifestyle Behaviors Scale II Score Change
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Five-times-sit-to-stand (FTSTS) test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in retinal electric activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in visual cortex response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in eye fundus tissue oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Oxygenation outcomes
Primary endpoint: Change in retinal capillaries density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Quality of life measured with EQ-5D-5L
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Bothersome Symptoms from baseline using the HIV Symptoms Index
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Phosphatidylethanol (PEth) Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Medications Prescribed Post Intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Protocol Uptake: Number of Children and Staff Consented Compared to Number of Approached
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in COVID Test Rate at School: Number of Total Child and Staff Tests Completed as Compared to Number of Tests Expected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in Positive Rate: Number of Positive COVID-19 Tests Compared to Total Number of Tests Performed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in EPA concentration in erythrocyte membrane
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of participants with treatment emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Respiratory-related evoked potentials (RREP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Maximum tolerated dose (MTD) of HS-10502
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum applicable dose (MAD) of HS-10502
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Rankin Scale score (mRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes